Riskpilot← Back to searchSign inGet full accessIndivior Nordics ApS
APSActiveCVR 36553014Nørregade 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20151 employees
Revenue 2024
DKK 13,4M
-5% vs 2023
EBITDA margin
9.8%
-29% vs 2023
Equity ratio
58.9%
Financial strength
Net profit 2024
DKK 1,3M
-16% vs 2023
| Revenue | DKK 13,4M | -5% |
| EBITDA | DKK 1,3M | -29% |
| Net profit | DKK 1,3M | -16% |
| Total assets | DKK 16,3M | +2% |
| Equity | DKK 9,6M | +12% |
| Employees | 1 | — |
Legal name
Indivior Nordics ApS
CVR number
36553014
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. februar 2015
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening
Company purpose
Selskabets formål er promovering af medicinale produkter, herunder import og salg, samt hermed beslægtet aktivitet herunder forskning, udvikling, markedsføring, registrering, licenser, og handel af kemiske og farmaceutiske produkter og andre varer af enhver art, enhver form for erhvervsaktivitet, der fremmer udviklingen af virksomheden og / eller støtter til virkeliggørelsen af selskabets formål, herunder at virksomheden kan købe, leje og sælge indenlandske og udenlandske ejendomme; kan deltage i andre selskaber, oprette filialer, agenturer og / eller repræsentationskontorer i bopælslandet og i udlandet og / eller erhverve, besidde og sælge rettigheder og værdipapirer af enhver art.
Address
Nørregade 21
Email
Info.Nordics@indivior.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -15 | 6.107 | 10.312 | 15.583 | 10.357 | 12.802 | 12.888 | 14.138 | 14.086 | 13.400 |
| Staff expenses | -0 | -4.894 | -9.226 | -11.472 | -9.023 | -11.198 | -11.398 | -12.275 | -12.228 | -12.086 |
| EBITDA | -15 | 1.213 | 1.086 | 4.111 | 1.334 | 1.604 | 1.490 | 1.863 | 1.849 | 1.314 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -15 | 1.213 | 1.086 | 4.111 | 1.334 | 1.604 | 1.490 | 1.863 | 1.849 | 1.314 |
| Net financials | 0 | -190 | -305 | -52 | -198 | -188 | -102 | 56 | 359 | 502 |
| Profit before tax | -15 | 1.023 | 781 | 4.059 | 1.135 | 1.415 | 1.388 | 1.920 | 2.208 | 1.815 |
| Tax | -0 | 232 | 431 | 792 | 581 | 299 | 1.025 | 571 | 698 | 552 |
| Net profit | -15 | 791 | 350 | 3.268 | 554 | 1.116 | 363 | 1.349 | 1.510 | 1.263 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 50 | 11.962 | 9.856 | 10.267 | 10.428 | 11.131 | 11.443 | 12.467 | 16.036 | 16.332 |
| Equity | 35 | 828 | 1.130 | 4.387 | 4.954 | 6.085 | 6.152 | 6.992 | 8.609 | 9.615 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 15 | 11.135 | 8.726 | 5.881 | 5.474 | 5.046 | 5.292 | 5.476 | 7.428 | 6.717 |
| Total debt | 15 | 11.135 | 8.726 | 5.881 | 5.474 | 5.046 | 5.292 | 5.476 | 7.428 | 6.717 |
EBITDA margin
9.8%
This company
15.8%
Market median
-38% vs market
20152024
Equity ratio
58.9%
This company
38.2%
Market median
+54% vs market
20152024
Return on equity
13.1%
This company
18.4%
Market median
+29% vs market
20152024
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20152024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20152024
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-02-20 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SE Management | Management | 2023 | — | — |
OM Management | Management | 2016 | — | — |
JP Management | Management | 2022 | — | — |
AC Management | Management | 2022 | — | — |
JK Management | Management | 2015 | — | — |
JA Management | Management | 2023 | — | — |
HM Management | Management | 2017 | — | — |
TW Management | Management | 2018 | — | — |
PA Management | Management | 2015 | — | — |
AE Management | Management | 2025 | — | — |
SR Management | Management | 2015 | — | — |
HM Management | Management | 2018 | — | — |
SH Management | Management | 2022 | — | — |
AJ Management | Management | 2015 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 | |
| Individual | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Indivior Nordics ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stephanie Elizabeth Mills | Management | 0 companies |
| Ole Meier Sørensen | Management | 0 companies |
| Jérôme Pierre Simon Guenee | Management | 0 companies |
| Abigail Christine Sheppard | Management | 0 companies |
| Jesper Krüger Mackowski | Management | 0 companies |
| Jan Anders Ahl | Management | 0 companies |
| Hans Martin Bergman | Management | 0 companies |
| Thomas Weis | Management | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Adam Elliott Wilson | Management | 0 companies |
| Simon Rye Clausen | Management | 0 companies |
| Hanneke Marieke Pelt | Management | 0 companies |
| Stig Holmegaard Jensen | Management | 0 companies |
| Andrew James Gawman | Management | 0 companies |